ImmuneSensor Therapeutics

Biotechnology, Health Care, Medical, Pharmaceutical
Founded in 1/1/19
Dallas, Texas, United States
For Profit

About ImmuneSensor Therapeutics

ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other autoimmune diseases. It is dedicated to developing new medicines that use the body's innate immune system to cure a variety of diseases. It was founded in 2019 and is based in Dallas, Texas, United States.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 26100000 USD
  • Last Funding: 10000000 USD (Venture - Series Unknown)
  • Funding Status:

Technology Stack

ImmuneSensor Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Medical, Pharmaceutical

Headquarters: Dallas, Texas, United States

Employees

  • Ernest Wong - Chief Executive Officer (LinkedIn)